Literature DB >> 29887707

Limb Salvage Versus Amputation in Conventional Appendicular Osteosarcoma: a Systematic Review.

Julio J Jauregui1, Vidushan Nadarajah1,2, Joseph Munn3, Robert Pivec2, Bhaveen H Kapadia2, Daniel M Lerman1, Aditya V Maheshwari2,4.   

Abstract

The overall survivorship in patients with appendicular osteosarcoma has increased in the past few decades. However, controversies and questions about performing an amputation or a limb salvage procedure still remain. Using three peer-reviewed library databases, a systematic review of the literature was performed to evaluate all studies that have evaluated the outcomes of appendicular osteosarcoma, either with limb salvage or amputation. The mean 5-year overall survivorship was 62% for salvage and 58% for amputation (p > 0.05). At mean 6-year follow-up, the local recurrence rates were 8.2% for salvage and 3.0% for amputation (p > 0.05). Additionally, at mean 6-year follow-up, the rate for metastasis was 33% for salvage and 38% for amputation (p > 0.05). The revision rates were higher with salvage (31 vs. 28%), and there were more complications in the salvage groups (52 vs. 34%; p > 0.05). Despite the heterogeneity of studies available for review, we observed similar survival rates between the two procedures. Although there was no significant statistical difference between rates of recurrence and metastasis, the local recurrence rate and risk of complications were higher for limb salvage as compared to amputation. Cosmetic satisfaction is often higher with limb salvage, whereas long-term expense is higher with amputation. Overall, current literature supports limb salvage procedures when wide surgical margins can be achieved while still retaining a functional limb.

Entities:  

Keywords:  Amputation; Complications; Limb salvage; Osteosarcoma; Survival rate; Survivorship

Year:  2018        PMID: 29887707      PMCID: PMC5984848          DOI: 10.1007/s13193-018-0725-y

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  48 in total

1.  Function and complications after ablative and limb-salvage therapy in lower extremity sarcoma of bone.

Authors:  A J Renard; R P Veth; H W Schreuder; C J van Loon; H S Koops; J R van Horn
Journal:  J Surg Oncol       Date:  2000-04       Impact factor: 3.454

2.  Neoadjuvant chemotherapy for extremity osteosarcoma--preliminary results of the Rizzoli's 4th study.

Authors:  G Bacci; S Ferrari; M Mercuri; A Longhi; R Capanna; A Tienghi; A Brach del Prever; A Comandone; M Cesari; G Bernini; P Picci
Journal:  Acta Oncol       Date:  1998       Impact factor: 4.089

3.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.

Authors:  Stefan S Bielack; Beate Kempf-Bielack; Günter Delling; G Ulrich Exner; Silke Flege; Knut Helmke; Rainer Kotz; Mechthild Salzer-Kuntschik; Matthias Werner; Winfried Winkelmann; Andreas Zoubek; Heribert Jürgens; Kurt Winkler
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

Review 4.  Expandable endoprostheses in malignant bone tumors in children: indications and limitations.

Authors:  Rainer Baumgart; Ulrich Lenze
Journal:  Recent Results Cancer Res       Date:  2009

Review 5.  Osteosarcoma.

Authors:  Patrick J Messerschmitt; Ryan M Garcia; Fadi W Abdul-Karim; Edward M Greenfield; Patrick J Getty
Journal:  J Am Acad Orthop Surg       Date:  2009-08       Impact factor: 3.020

6.  Prognosis of osteosarcoma treated by limb-salvage surgery: the ten-year intergroup study in Japan.

Authors:  H Tsuchiya; K Tomita
Journal:  Jpn J Clin Oncol       Date:  1992-10       Impact factor: 3.019

7.  Paget's osteosarcoma and post-radiation osteosarcoma: secondary osteosarcoma at Middlemore Hospital, New Zealand.

Authors:  Michael S Dray; Mary V Miller
Journal:  Pathology       Date:  2008-10       Impact factor: 5.306

8.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

Review 9.  Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing's sarcoma.

Authors:  Xing Dai; Wei Ma; Xijing He; Rajiv Kumar Jha
Journal:  Med Sci Monit       Date:  2011-08

10.  Meta-analysis of limb salvage versus amputation for treating high-grade and localized osteosarcoma in patients with pathological fracture.

Authors:  Ke Yin; Qiande Liao; DA Zhong; Jie Ding; Bing Niu; Qiupping Long; Dengfeng Ding
Journal:  Exp Ther Med       Date:  2012-08-28       Impact factor: 2.447

View more
  10 in total

Review 1.  Limb-salvage surgery offers better five-year survival rate than amputation in patients with limb osteosarcoma treated with neoadjuvant chemotherapy. A systematic review and meta-analysis.

Authors:  Evgenia Papakonstantinou; Alexandros Stamatopoulos; Dimitrios I Athanasiadis; Efstathios Kenanidis; Michael Potoupnis; Anna-Bettina Haidich; Eleftherios Tsiridis
Journal:  J Bone Oncol       Date:  2020-09-15       Impact factor: 4.072

2.  Factors Affecting Prognosis and Survival in Extremity Osteosarcoma.

Authors:  Anvesh Dharanikota; Ravi Arjunan; Ashwathappa Dasappa
Journal:  Indian J Surg Oncol       Date:  2021-01-06

3.  Extreme bone lengthening by bone transport with a unifocal tibial corticotomy: a case report.

Authors:  Hongjie Wen; Huagang Yang; Yongqing Xu
Journal:  BMC Musculoskelet Disord       Date:  2019-11-20       Impact factor: 2.362

Review 4.  Sarcoma treatment in the era of molecular medicine.

Authors:  Thomas Gp Grünewald; Marta Alonso; Sofia Avnet; Ana Banito; Stefan Burdach; Florencia Cidre-Aranaz; Gemma Di Pompo; Martin Distel; Heathcliff Dorado-Garcia; Javier Garcia-Castro; Laura González-González; Agamemnon E Grigoriadis; Merve Kasan; Christian Koelsche; Manuela Krumbholz; Fernando Lecanda; Silvia Lemma; Dario L Longo; Claudia Madrigal-Esquivel; Álvaro Morales-Molina; Julian Musa; Shunya Ohmura; Benjamin Ory; Miguel Pereira-Silva; Francesca Perut; Rene Rodriguez; Carolin Seeling; Nada Al Shaaili; Shabnam Shaabani; Kristina Shiavone; Snehadri Sinha; Eleni M Tomazou; Marcel Trautmann; Maria Vela; Yvonne Mh Versleijen-Jonkers; Julia Visgauss; Marta Zalacain; Sebastian J Schober; Andrej Lissat; William R English; Nicola Baldini; Dominique Heymann
Journal:  EMBO Mol Med       Date:  2020-10-13       Impact factor: 12.137

5.  High expression of ABCG2 is associated with chemotherapy resistance of osteosarcoma.

Authors:  Hao Shu; Bin Yuan; Yao Huang; Lei Wang; Bing He; Qi Sun; Luning Sun
Journal:  J Orthop Surg Res       Date:  2021-01-28       Impact factor: 2.359

6.  The risk for complications and reoperations with the use of mega prostheses in bone reconstructions.

Authors:  Christina Berger; Sofia Larsson; Peter Bergh; Helena Brisby; David Wennergren
Journal:  J Orthop Surg Res       Date:  2021-10-14       Impact factor: 2.677

7.  Amputation Predisposes to Higher Cancer-Specific Mortality Than Limb Salvage Surgery in Pediatric Patients With Osteosarcoma of the Limbs: A Propensity Matching Analysis.

Authors:  Jinkui Wang; Jie Tang; Xiaojun Tan; Chenghao Zhanghuang; Liming Jin; Mujie Li; Zhaoxia Zhang; Tao Mi; Dawei He
Journal:  Front Surg       Date:  2022-02-09

8.  [Application of pasteurized tumor-bearing bone replantation for primary malignant bone tumor of extremities].

Authors:  Hao Wu; Hanhua Wu; Maolin He
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-12-15

9.  Comparative efficacy of intraoperative extracorporeal irradiated and alcohol-inactivated autograft reimplantation for the management of osteosarcomas-a multicentre retrospective study.

Authors:  Meitao Xu; Ming Xu; Shuai Zhang; Hanqing Li; A I Qiuchi; Xiuchun Yu; Xu Quan Wang
Journal:  World J Surg Oncol       Date:  2021-05-26       Impact factor: 2.754

10.  Clinical Outcome of Free Vascularized Fibula Graft in the Surgical Treatment of Extremity Osteosarcoma.

Authors:  Leilei Xu; Li Wen; Jun Qiao; Zezhang Zhu; Yong Qiu; Jin Xiong; Haijun Mao; Shoufeng Wang
Journal:  Orthop Surg       Date:  2020-05-15       Impact factor: 2.071

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.